NCT06030544View on ClinicalTrials.gov

Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 25, 2022

Primary Completion Date

March 20, 2025

Study Completion Date

June 30, 2025

Conditions
Diabetic PatientsType II Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

OA-enriched functional olive oil

Dietary intervention in diabetic patients. Oral intake of 55 mL/day of a functional olive oil enriched in Oleanolic acid (equivalent dose 30 mg/day OA) Oleanolic acid (CAS no. 598-02-1; PubChem CID 10494).

DIETARY_SUPPLEMENT

commercial olive oil

Dietary intervention in diabetic patients. Oral intake of 55 mL/day of a commercial olive oil (blend of virgin and refined olive oils) chosen by its very low content of bioactive minor components.

Trial Locations (1)

41013

Virgen del Rocío University Hospital, Seville

All Listed Sponsors
collaborator

Andalusian Health Service

OTHER_GOV

collaborator

Universidad Pablo de Olavide

OTHER

lead

Spanish National Research Council

OTHER_GOV